Blog Posts
PARP Inhibitor

The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:

“Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data – The Lancet Oncology

This prospective cohort study from Denmark investigated the potential association between aromatase inhibitor treatment (AIT) and ischemic cardiotoxicity in postmenopausal women with early Breast Cancer.”

ischaemic cardiotoxicity

Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data

Authors: Marie Luna, Giulia Corn, Maj-Britt Jensen, Tonny Petersen, Kim Dalhoff, Bent Ejlertsen, Lars Køber, Jan Wohlfahrt , Mads Melbye

The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer

More posts featuring Elisabetta Bonzano.

Bent Ejlertsen cancer Giulia Corn Jan Wohlfahrt Kim Dalhoff Lars Køber Mads Melbye Maj-Britt Jensen Marie Luna OncoDaily Oncology Tonny Petersen